• Natural products remain a rich source of anticancer leads, with several compounds in clinical trials targeting novel pathways.
• Advanced screening and AI-driven approaches are significantly accelerating the discovery of bioactive natural compounds.
• Combination therapies using natural products can help overcome multidrug resistance in cancer cells.
• Sustainable sourcing and synthetic biology are critical for ensuring the future availability of promising natural product drugs.